Chargement en cours...
MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies
The present study was undertaken to estimate the therapeutic benefit to down-regulate the MUC4 mucin for reversing chemoresistance of pancreatic cancer (PC) stem/progenitor cells and their progenies. The results have revealed that MUC4 mucin is overexpressed in CD133(+) and CD133(−) pancreatic cells...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2891434/ https://ncbi.nlm.nih.gov/pubmed/20303649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2010.02.015 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|